Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.505, 2006-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lenograstim + chemotherapy for small cell lung cancer: cost effectiveness "finely balanced"
Inpharma, Vol. 1, Iss. 1542, 2006-01 ,pp. :
Access to resources
Recommend
Lenograstim improves survival without compromising QOL in SCLC
Inpharma, Vol. 1, Iss. 1230, 2000-01 ,pp. :
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Balancing cost effectiveness and innovation
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 531, 2007-01 ,pp. :
Cost effectiveness of ixabepilone debated
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 576, 2009-01 ,pp. :